You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 3551 to 3575 of about 6087
Next 25
02/02/2009
Updated article: State of the Art treatments for gbms
Safety and Efficacy of Bevacizumab with Hypofractionated Stereotactic Irradiation for Recurrent Malignant Gliomas.
01/29/2009
Antibodies for brain tumors - TV News story
01/28/2009
Texas Hold`em Tournament in NY to benefit Children`s Brain Tumor Foundation
Fundraiser: Serenity Soap N Shower
01/24/2009
Added new video on a vaccine trial for low grade glioma and oligodendroglioma and updated video on vaccine for glioblastoma
01/22/2009
NOVEL DEVICE SHOWN TO BENEFIT SURVIVAL FOR BRAIN CANCER PATIENTS WHEN COMBINED WITH CHEMOTHERAPY
01/17/2009
Association Between Hyperglycemia and Survival in Patients With Newly Diagnosed Glioblastoma.
01/15/2009
New vaccine trial opens for people with low grade astrocytoma and oligodendrogliomas
01/12/2009
NCI Proposes Cuts to Funding for Adult Brain Tumor Consortium
Gene therapy eliminates brain tumors through selective recruitment of immune cells
01/09/2009
Is There A Brain Tumor Virus?
Medication Errors Among Adults and Children With Cancer in the Outpatient Setting.
01/07/2009
Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma.
01/05/2009
Musella Foundation awards brain tumor research grant!
Fundraiser in NYC to benefit the brain tumor center at Duke!
Salk researchers create brain cancer mouse model
01/03/2009
CD offers `Hope` to patients
12/31/2008
Fatigue in low-grade glioma
Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results.
Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival.
Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma.
National Brain Tumor Society - Regional Conference in San Francisco, CA